Sage Therapeutics, Inc.
SAGE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$401 | -$541 | -$533 | -$458 |
| Dep. & Amort. | -$5 | $1 | $1 | $4 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $55 | $73 | $62 | $105 |
| Change in WC | $85 | -$67 | $6 | -$19 |
| Other Non-Cash | -$0 | -$6 | $4 | -$11 |
| Operating Cash Flow | -$267 | -$541 | -$460 | -$378 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | -$326 | $1,002 |
| Inv. Purchases | -$451 | -$595 | -$881 | -$1,990 |
| Inv. Sales/Matur. | $718 | $1,038 | $1,207 | $988 |
| Other Inv. Act. | $0 | $0 | $326 | -$1,002 |
| Investing Cash Flow | $267 | $443 | $325 | -$1,002 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $8 | $7 | $3 | $15 |
| Stock Repurch. | $0 | -$1 | -$0 | -$1 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $6 | $3 | $13 |
| Financing Cash Flow | $11 | $6 | $3 | $13 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $10 | -$92 | -$132 | -$1,367 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $72 | $164 | $296 | $1,663 |
| End Cash | $82 | $72 | $164 | $296 |
| Free Cash Flow | -$267 | -$541 | -$461 | -$379 |